Deliver to United Kingdom
0

HPLC column NUCLEOSHELL ® RP 18, 5 µm, 150 mm, 3 mm

£ 812.70*

*Prices plus VAT plus shipping costs

£ 975.24*

*incl. VAT, plus shipping costs

HPLC column NUCLEOSHELL ® RP 18, 5 µm, 150 mm, 3 mm

Order number: 3634.1

Part number: AC100007377

In Stock

Price Breakdown

1

6

24

Prepared for use in regulated laboratory conditions, the Hplc Column Nucleoshell Rp 18, 5 μm, 150 Mm, 3 Mm falls under the category of Separation columns for HPLC. This analytical separation column features a Reversed phase (RP) separation principle and a High density monomeric octadecyl (C 18 , ODS) modification, Base deactivated (BDS), making it ideal for separating basic and other ionizable analytes. With a Pore size of 90 Å and a Pore volume of 0.9 ml/g, this column offers excellent pH stability ranging from 1,0 to 11,0, ensuring compatibility with LC/MS applications. The column's Pressure stability of 600 bar and Temperature stability of 60 ° C further enhance its versat

  • Category: Separation columns for HPLC
  • Surface chemistry: High density monomeric octadecyl (C 18 , ODS) modification, Base deactivated (BDS)
  • Phase: RP 18
  • Temperature stability: 60 ° C
  • L x Ø internal (column): 150 x 3 mm
  • Pressure stability: 600 bar
  • Pore volume: 0.9 ml/g
  • Interactions / retention mechanism: hydrophobic (van der Waals)
  • USP listing: L1
  • Pore size: 90 Å
  • pH stability: 1,0-11,0
  • Column volume: 1.05 ml
  • Particle size: 5 µm
  • Endcapped: yes
  • Separation principle: Reversed phase (RP)
  • Particle type: Core-shell, superficially porous particles (SPP)
  • Column shape: Analytical separation column
  • Specific surface according to BET: 90 m²/g
  • Recommended application(s): Antibiotics Antidepressants Anti-inflammatory drugs Herbicides Immunosuppressants Phytopharmaceuticals Suitable for LC-MS
  • Eluent in column: Acetonitrile - Water
  • Column type: HPLC column
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.